Can your own blood help regrow hair? new trial tests PRP for scarring hair loss

NCT ID NCT06998433

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether platelet-rich plasma (PRP) injections can help treat central centrifugal cicatricial alopecia (CCCA), a scarring hair loss that mostly affects women of African descent. PRP is made from a patient's own blood and is thought to reduce inflammation and promote healing. The trial will compare PRP to a placebo in 56 women, with all participants continuing standard topical steroid treatment. The goal is to see if PRP can stop hair loss and encourage regrowth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Platelet-Rich Plasma (PRP) injections

What this could lead to

If it works, this could point toward a new treatment option for central centrifugal cicatricial alopecia (CCCA), a type of scarring hair loss that currently has no standard treatment guidelines.

What could go wrong

This is a small, early-phase trial with only 56 participants, so results may not apply to everyone. PRP is generally safe but may cause minor discomfort from injections, and there is a small risk of disease progression.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia central centrifugal cicatricial alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Jamail Specialty Care Center

    Houston, Texas, 77030, United States